AQST vs CLOV · rev $57.6M vs rev $1.37B
Aquestive Therapeutics Inc (AQST) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Aquestive Therapeutics Inc (AQST) is a drug manufacturers - specialty & generic company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported AQST revenue for 2024-12-31 was $57.6M. Net income was -$44.1M. Revenue was up 13.8% from 2023-12-31 to 2024-12-31. AQST currently screens at market cap $493.0M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
AQST currently screens at market cap $493.0M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the AQST and CLOV stock pages for the full models.
Not investment advice.